XOMA Royalty Corporation

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals

Other Names/Subsidiaries

  • Enumeral Biomedical
  • Kinnate Biopharma
  • Pulmokine
  • Xoma
See more in Biomedtracker

Latest on XOMA Royalty Corporation

Scrip

Pierre Fabre Pushes To Be Partner Of Choice For Budding Biotechs

 
• By Kevin Grogan

Pierre Fabre may have shunned the spotlight but the French group, which is arguably best known for its significant beauty care arm, is making major strides in becoming an attractive partner for innov

Scrip

Deal Watch: Biogen, AbCellera Team To Find Novel Way To Cross Blood-Brain Barrier

 
• By Joseph Haas and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biogen’s Pact With AbCellera Will Focus

Scrip

Deal Watch: AbbVie Adds To Immunology Pipeline Through Deal With OSE

 
• By Joseph Haas, Dexter Jie Yan, and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie To Pay $48m Up Front For Preclin

Pink Sheet

Preterm Birth Patients Sought By US FDA As Meeting On Treatment Development Looms

 
• By Derrick Gingery

The US Food and Drug Administration is urgently seeking patients that have experienced preterm birth with the market now devoid of treatments and a workshop on developing new therapies upcoming. A 30